Treatment of toxic epidermal necrolysis with intravenous immunoglobulin in children
Authors:
- Marta J. PetersenaMPMarta J. Petersena
- Jeffrey R. SaffleJSJeffrey R. Saffle
- Stephen E. MorrisSMStephen E. Morris
- John J. ZoneJZJohn J. Zone
- 1 October 2002
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 47 (4) , 548-552
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- TOXIC EPIDERMAL NECROLYSISDermatologic Clinics, 2000
- Treatment of Toxic Epidermal Necrolysis with Cyclosporin A2000
- Treatment issues in the care of patients with toxic epidermal necrolysisBurns, 1999
- Would Cyclosporin A Be Beneficial to Mitigate Drug-Induced Toxic Epidermal Necrolysis?Dermatology, 1999
- Plasmapheresis as an adjunct treatment in toxic epidermal necrolysisJournal of the American Academy of Dermatology, 1999
- Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysisThe Lancet, 1998
- Experience With Toxic Epidermal Necrolysis Treated in a Burn CenterJournal of Burn Care & Rehabilitation, 1996
- Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal NecrolysisNew England Journal of Medicine, 1995
- A Comprehensive ApproachClinical Pediatrics, 1989
- Improved Burn Center Survival of Patients with Toxic Epidermal Necrolysis Managed without CorticosteroidsAnnals of Surgery, 1986